PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15007625-4	2004	We exploited the power of yeast genetics to isolate for the first time several bleomycin-resistant mutants derived from a strain deleted for the IMP2 gene encoding a transcriptional co-activator.	Bleomycin	79-88	endopeptidase catalytic subunit	Saccharomyces cerevisiae S288C	145-149	
14558142-7	2003	Moreover, the interaction between IMP2 and GAL6/BLH1, a recently isolated gene involved in the regulation of GAL genes that shares with Imp2 the ability to protect cells from the glycopeptide bleomycin, was also analysed.	Bleomycin	192-201	endopeptidase catalytic subunit	Saccharomyces cerevisiae S288C	34-38	
14558142-7	2003	Moreover, the interaction between IMP2 and GAL6/BLH1, a recently isolated gene involved in the regulation of GAL genes that shares with Imp2 the ability to protect cells from the glycopeptide bleomycin, was also analysed.	Bleomycin	192-201	endopeptidase catalytic subunit	Saccharomyces cerevisiae S288C	136-140	
8628275-0	1996	The Saccharomyces cerevisiae IMP2 gene encodes a transcriptional activator that mediates protection against DNA damage caused by bleomycin and other oxidants.	Bleomycin	129-138	endopeptidase catalytic subunit	Saccharomyces cerevisiae S288C	29-33	
10546901-3	1999	In the yeast Saccharomyces cerevisiae, the transcriptional activator Imp2 is required to fend off the toxic effects of bleomycin.	Bleomycin	119-128	endopeptidase catalytic subunit	Saccharomyces cerevisiae S288C	69-73	
10546901-4	1999	However, it remains unclear whether Imp2 controls the expression of a protein that either repairs bleomycin-induced DNA lesions, or detoxifies the drug, and or both.	Bleomycin	98-107	endopeptidase catalytic subunit	Saccharomyces cerevisiae S288C	36-40	
8628275-4	1996	A DNA clone containing the IMP2 gene that complemented the most sensitive bleomycin mutant was identified.	Bleomycin	74-83	endopeptidase catalytic subunit	Saccharomyces cerevisiae S288C	27-31	
8628275-5	1996	A role for IMP2 in defense against the toxic effects of bleomycin has not been previously reported.	Bleomycin	56-65	endopeptidase catalytic subunit	Saccharomyces cerevisiae S288C	11-15	
8628275-6	1996	imp2 null mutants were constructed and were found to be 15-fold more sensitive to bleomycin than wild-type strains.	Bleomycin	82-91	endopeptidase catalytic subunit	Saccharomyces cerevisiae S288C	0-4	
24599794-0	2014	Upregulation of the Saccharomyces cerevisiae efflux pump Tpo1 rescues an Imp2 transcription factor-deficient mutant from bleomycin toxicity.	Bleomycin	121-130	endopeptidase catalytic subunit	Saccharomyces cerevisiae S288C	73-77	
24599794-1	2014	Yeast mutants lacking the transcriptional co-activator Imp2 are hypersensitive to the anticancer drug bleomycin, although the gene targets involved in this process remain elusive.	Bleomycin	102-111	endopeptidase catalytic subunit	Saccharomyces cerevisiae S288C	55-59